Joshua EllisMD, MSc

MD · Harvard

Residency · Internal Medicine Residencyalumni

publications

first author

median RCR

0.76

citations

Publications

2026
Inpatient initiation of tuberculosis preventive therapy with 1 month of isoniazid and rifapentine for adults with advanced HIV disease and cryptococcal meningitis (IMPROVE): a non-inferiority, randomised controlled trial.
The lancet. HIVfirst author2 citesPMID 41662846
2025
Epstein-Barr Virus Central Nervous System Infections and Mortality Risk in Patients Presenting With Suspected Meningitis: Results From the Botswana National Meningitis Survey and the Harare Meningitis Aetiology Study.
Open forum infectious diseasesfirst author0 citesPMID 41322245
2025
Epstein-Barr virus and cytomegalovirus co-infections and mortality risk in patients with HIV-associated cryptococcal meningitis: a post-hoc analysis of a prospective nested cohort in the AMBITION-cm randomised controlled trial.
The lancet. HIVfirst author3 citesPMID 40915307
2025
Valganciclovir for cytomegalovirus viraemia in advanced HIV disease: a phase 2b randomized placebo-controlled trial of valganciclovir for cytomegalovirus viraemia in adults and adolescents with advanced HIV disease.
Philosophical transactions of the Royal Society of London. Series B, Biological sciencesfirst author1 citesPMID 41194665
2024
Integrated management of cryptococcal meningitis and concurrent opportunistic infections to improve outcomes in advanced HIV disease: a randomised strategy trial.
Wellcome open researchfirst authorRCR 0.764 citesPMID 38854693

Compiled from public program rosters and open scholarly data (PubMed, OpenAlex, ORCID) with field-normalized impact (NIH iCite RCR). Publication attribution is being actively improved; counts shown are conservative.